Menu
Close

Cannabidiol

lse:fum

#1

Dermasys is now to be used to explore transdermal transfer of cannabidiol for pain treatment in conjunction with CBderma Technology Limited:

https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/FUM/14219782.html

Who the heck are CBderma?? This is a brand new company, based in Bristol, with a single shareholder named Anthony Michael Parker. Who the heck is he??

https://suite.endole.co.uk/insight/company/12133619-cbderma-technology-limited

All that Google could provide me based on that name is an American ex-basketball player. But the D. of B. are different.

I cannot get over excited about this dearth of info. Does anyone else have any insights?


#2

From what I can see on Google, looks like beaglepartners.com may be relevant.


#3

Well done, yes. Same company addresses too.


#4

Seemed a +ve RNS to me.
Will continue trying to view FUM through the same eyes as LOAM.


#5

Timing of this JV seems significant to me also.


#6

A JV to not be incorporated in a future sale…hopefully.


#7

Exactly.
Somebody on lse posted this interesting link www.argonauterna.com .
The new investor(s) clearly has much relevant experience.